R F Rando - JoVE Visualize

Showing results (41-50 of 55) with videos related to

Pageof 6

Sort By:

Nucleosides & Nucleotides|August 26, 1998

Convenient approaches to the synthesis of oligonucleotide macrocycles containing non-nucleotide linkersV A Efimov, A A Buryakova, A L Kalinkina, et al.

Antimicrobial Agents and Chemotherapy|March 18, 2000

Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirusJ Bedard, S May, L L'Heureux, et al.

Biochemical Pharmacology|November 22, 1996

Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicityL Cui, R F Schinazi, G Gosselin, et al.

Molecular Pharmacology|November 14, 1997

Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1P Cherepanov, J A Esté, R F Rando, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994

Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted virusesK Berencsi, A Uri, T Valyi-Nagy, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1994

Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring systemA F Lewis, J C Drach, S M Fennewald, et al.

The Journal of Biological Chemistry|March 8, 1996

Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotideJ S Bishop, J K Guy-Caffey, J O Ojwang, et al.

Antimicrobial Agents and Chemotherapy|January 27, 2006

In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infectionZ Gu, B Allard, J M de Muys, et al.

Antimicrobial Agents and Chemotherapy|August 3, 1999

Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidineJ M de Muys, H Gourdeau, N Nguyen-Ba, et al.

Molecular Pharmacology|March 14, 1998

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.

Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:

Pageof 6

Nucleosides & Nucleotides|August 26, 1998

Convenient approaches to the synthesis of oligonucleotide macrocycles containing non-nucleotide linkersV A Efimov, A A Buryakova, A L Kalinkina, et al.

Antimicrobial Agents and Chemotherapy|March 18, 2000

Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirusJ Bedard, S May, L L'Heureux, et al.

Biochemical Pharmacology|November 22, 1996

Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicityL Cui, R F Schinazi, G Gosselin, et al.

Molecular Pharmacology|November 14, 1997

Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1P Cherepanov, J A Esté, R F Rando, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994

Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted virusesK Berencsi, A Uri, T Valyi-Nagy, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1994

Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring systemA F Lewis, J C Drach, S M Fennewald, et al.

The Journal of Biological Chemistry|March 8, 1996

Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotideJ S Bishop, J K Guy-Caffey, J O Ojwang, et al.

Antimicrobial Agents and Chemotherapy|January 27, 2006

In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infectionZ Gu, B Allard, J M de Muys, et al.

Antimicrobial Agents and Chemotherapy|August 3, 1999

Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidineJ M de Muys, H Gourdeau, N Nguyen-Ba, et al.

Molecular Pharmacology|March 14, 1998

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.

Pageof 6